Management of Newly Diagnosed Type 2 Diabetes with Multiple Comorbidities

Glycemic Management

The American College of Physicians recommends starting metformin immediately as first-line therapy for newly diagnosed patients with HbA1c 8%, unless contraindicated by reduced eGFR of 35 ml/min, with a strength of evidence of high 1
Dual therapy should be strongly considered from the outset, adding a second agent such as a DPP-4 inhibitor or basal insulin if metformin is contraindicated due to renal function, based on moderate evidence 1
The American Diabetes Association recommends avoiding sulfonylureas in patients with impaired renal function and increased hypoglycemia risk, with a strength of evidence of moderate 1
SGLT2 inhibitors should be avoided given eGFR of 35 ml/min, as they are less effective and carry ketoacidosis risk at this level of renal function, based on high evidence 1
Target HbA1c should be individualized, but achieving near-normoglycemia is critical to prevent progression of microvascular complications, with a strength of evidence of high 3, 5, 6

The American Academy of Neurology recommends initiating pregabalin 75 mg twice daily, titrating up to 300-600 mg/day in divided doses as tolerated, for diabetic peripheral neuropathy, with a strength of evidence of high 2, 3, 4, 7
Alternative first-line options include duloxetine 60 mg daily, gabapentin 900-3600 mg/day in divided doses, or tricyclic antidepressants, based on moderate evidence 2, 3, 4, 6, 7
Gabapentinoids, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, and sodium channel blockers are all recommended as initial pharmacologic treatments for neuropathic pain in diabetes, with a strength of evidence of high 6
Optimizing glycemic control is essential to prevent or delay diabetic peripheral neuropathy progression, though it will not reverse existing neuronal loss, based on high evidence 3, 4, 5, 6

The American Heart Association recommends starting an ACE inhibitor or ARB immediately for dual benefit of blood pressure control and slowing progression of diabetic kidney disease, with a strength of evidence of high 2, 3, 4, 8
ACE inhibitors or ARBs are specifically indicated to slow kidney disease progression in hypertensive diabetic patients with eGFR <60 ml/min, based on high evidence 2, 3, 4, 8
Urgent nephrology referral is mandatory given eGFR of 35 ml/min and elevated creatinine, representing advanced kidney disease requiring specialist input, with a strength of evidence of high 2, 3, 4

The American College of Cardiology recommends initiating high-intensity statin therapy given severely elevated LDL, total cholesterol, low HDL, and elevated triglycerides, with a strength of evidence of high 2, 3, 8
Do not add fibrate therapy to statin, as combination therapy has not been shown to improve ASCVD outcomes, based on moderate evidence 2, 3
Optimizing lipid control is critical for reducing risk and slowing progression of diabetic retinopathy and neuropathy, with a strength of evidence of high 2, 3, 6, 8

The American Heart Association recommends starting aspirin 75-162 mg daily for primary prevention given 10-year ASCVD risk >10%, with a strength of evidence of high 2, 3, 4, 8
His cardiovascular risk factors include age, diabetes, hypertension, dyslipidemia, smoking, and family history, placing him at very high cardiovascular risk, based on high evidence 2, 3, 4, 8

Immediate smoking cessation is mandatory, given 30 pack-year smoking history dramatically increasing risk for cardiovascular disease, peripheral arterial disease, foot ulceration, and amputation, with a strength of evidence of high 9, 4, 10
Alcohol cessation or dramatic reduction is essential, as consuming alcohol contributes to poor glycemic control, hypertriglyceridemia, hypertension, and may worsen neuropathy, based on moderate evidence 7
Weight loss of 5-10% through caloric restriction and increased physical activity will improve glycemic control, blood pressure, and lipid profile, with a strength of evidence of high 1

Comprehensive ophthalmologic examination by ophthalmologist or optometrist is required immediately, given new diabetes diagnosis, with a strength of evidence of high 2, 3, 4, 8
Annual foot examination with 10-g monofilament testing plus assessment of pinprick, vibration, ankle reflexes, skin integrity, deformities, and pedal pulses should be performed, based on high evidence 2, 9, 4, 8, 10
Obtain baseline urine albumin-to-creatinine ratio to assess degree of albuminuria and establish baseline for monitoring kidney disease progression, with a strength of evidence of high 2, 3, 4, 8